About: COVID-19: Clinical aspects and therapeutics responses

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: COVID-19: Clinical aspects and therapeutics responses Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	COVID-19: Clinical aspects and therapeutics responses
Creator	Wang, W Han, Guang Khan, Suliman Han, M Shi, R Siddique, Rabeea Ali, Ashaq Shi, Hongwei Wang, Tiejun Zaman, Wajid Hu, Junjie Dong, Men Dong, T Guang, / Siddique, A Zaman, J
Source	Elsevier; Medline; PMC
abstract	COVID-19 has created havoc in the world by causing thousands of demises in a short period of time. Up till now, several attempts have been made for potential therapeutics against SARS-COV2. In this retrospective, single-center study, we extracted data from 122 COVID-19, RT-PCR confirmed patients. who were treated with a new treatment strategy of lianhuaqingwen with Arbidol Hydrochloride. The patients were either asymptomatic or had mild symptoms for COVID-19 disease. Of 122 patients 21 (17.21%) patients undergo severe conditions of COVID-19, However total 111 (90.9 %) experienced mild symptoms such as fever in 93 (76.22%) patients, cough in 23 (20.17%) and muscle pain were observed in total 8 (7%) patients. Furthermore our newly applied combination (Lianhuaqingwen and Arbidol Hydrochloride) showed effects in 5-7 days for patients with mild symptoms and was found effective with 98 % recovery rate. We found the new combination is very effective against patients with mild symptoms and asymptomatic patients. Further extensive clinical investigations are required.
has issue date	2020-07-03(xsd:dateTime)
bibo:doi	10.1016/j.jsps.2020.06.022
bibo:pmid	32788835
has license	no-cc
sha1sum (hex)	afe1861fef59382bfe9d04ab9d55a7ea24e8bcdd
schema:url	https://doi.org/10.1016/j.jsps.2020.06.022
resource representing a document's title	COVID-19: Clinical aspects and therapeutics responses
has PubMed Central identifier	PMC7332461
has PubMed identifier	32788835
schema:publication	Saudi Pharm J
resource representing a document's body	covid:afe1861fef59382bfe9d04ab9d55a7ea24e8bcdd#body_text
is schema:about of	named entity 'data' named entity 'patients' named entity 'muscle pain' named entity 'CONDITIONS' named entity 'MILD SYMPTOMS' named entity 'RT-PCR' named entity 'JOURNAL ' named entity 'ARTICLE' named entity 'THERAPEUTICS' named entity 'CLINICAL ASPECTS' named entity 'COVID-19' named entity 'patients' named entity 'COVID-19' named entity 'total' named entity 'confirmed' named entity 'disease' named entity 'symptoms' named entity 'total' named entity 'retrospective' named entity 'period' named entity 'fever' named entity 'cough' named entity 'COVID-19' named entity 'COVID-19 disease' named entity 'COVID-19' named entity 'However' named entity 'asymptomatic patients' named entity 'hypertension' named entity 'diarrhea' named entity 'headache' named entity 'fatigue' named entity 'COVID' named entity '85%' named entity 'incubation period' named entity 'National Health Commission of China' named entity 'asthma' named entity 'COVID-19' named entity 'symptom' named entity 'TCM' named entity 'infection' named entity 'mechanism of action' named entity 'WBC' named entity 'Forsythia suspensa' named entity 'traditional Chinese medicine' named entity 'tablets' named entity 'lymphopenia' named entity 'protein' named entity 'COVID' named entity 'fever' named entity 'Hubei' named entity 'inflammation' named entity 'asymptomatic' named entity 'asymptomatic patients' named entity 'antiviral drug' named entity 'TCM' named entity 'breathing rate' named entity 'myalgia' named entity 'cough' named entity 'signs and symptoms' named entity 'clinical investigations' named entity 'Hydrochloride' named entity 'COVID-19' named entity 'asymptomatic' named entity 'COVID' named entity 'neutrophil' named entity 'innate immunity'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software